Aortic Regurgitation Workup
- Author: Stanley S Wang, MD, JD, MPH; Chief Editor: Richard A Lange, MD more...
Laboratory Studies
Laboratory testing in patients with aortic regurgitation (AR) should be guided by the clinical scenario. For example, in patients with AR due to suspected infective endocarditis, peripheral blood counts and cultures may help clarify the diagnosis and identify the causative organism. Specific serologic tests may assist in the diagnosis of rheumatological causes. Laboratory assessment of renal and hepatic function may play an important role in determining a patient's eligibility for certain vasodilator or other drug therapy.
Imaging Studies
- Transthoracic echocardiography should be performed in all patients with suspected AR, and periodically in patients with confirmed AR of significant severity. Echocardiography is a highly accurate test in AR, with sensitivity and specificity well in excess of 90%. In addition, echocardiographic parameters are used to determine the optimal timing of surgery in many cases.[5] Important echocardiographic findings in AR include the following:
- Aortic valve structure and morphology (bileaflet versus trileaflet, flail, thickening)
- Presence of vegetations or nodules (may require transesophageal echocardiography in selected cases)
- Severity of AR
- Color Doppler jet width (the vena contracta width is usually >65% of the width of the left ventricular outflow tract in severe AR)
- Vena contracta width
- Regurgitant volume, fraction, and orifice area
- Premature closure of the mitral valve (seen in severe AR) and opening of the aortic valve (with severely elevated LV end-diastolic pressure)
- Pressure half-time (usually < 300-350 ms with significant AR)
- Associated lesions of the aorta, including dilation, aneurysm, dissection, or ectasia
- LV structure and function
- LV hypertrophy and dilation
- EF and end-systolic dimension are key determinants of outcome
- Surgery recommended if EF is ≤ 55% or if end-systolic dimension is >55 mm[5]
- Standard chest radiography may show evidence of structural abnormalities (aortic dilation, prosthetic valve dislodgement, aortic valvular calcification) or functional compromise (pulmonary edema, cardiomegaly).
- Radionuclide imaging may provide complementary clinical information, including AR regurgitant fraction and LV/RV stroke volume ratio (often >2 in severe AR).
- Cardiac computed tomography (CT) and magnetic resonance imaging (MRI) have not yet achieved widespread adoption in the management of AR, although support in the literature is increasing for the potential clinical use of these imaging techniques.[18, 19, 20]
Other Tests
- Electrocardiography findings are nonspecific but may include evidence of the following:
- LV hypertrophy
- Left axis deviation
- Left atrial enlargement
- LV volume overload pattern (prominent Q waves in leads I, aVL, and V3 to V6 and relatively small r waves in V1)
- LV conduction defects (typically late in the disease process)
- Exercise treadmill testing may be used to guide recommendations for surgical therapy in patients with chronic severe AR and equivocal symptoms.[5] However, the role of stress echocardiography in patients with AR remains uncertain, and further studies may be needed before it can be recommended for routine clinical use.[21]
Procedures
- Cardiac catheterization is not always required in all patients with chronic AR but may provide extremely valuable clinical information, especially in patients who are contemplating surgery. Class I indications for cardiac catheterization under current American College of Cardiology/American Heart Association guidelines include the following:[5]
- Assessment of coronary anatomy prior to aortic valve surgery in patients with risk factors for coronary artery disease
- Assessment of severity of AR, LV function, or aortic root size when noninvasive tests are inconclusive or discordant with clinical findings
- Aortic angiography, which may be performed during a cardiac catheterization procedure, may provide useful information regarding the severity of the patient's AR. Traditional angiographic grading is as follows:
- Mild (1+): A small amount of contrast enters the left ventricle during diastole and clears with each systole.
- Moderate AR (2+): Contrast enters the LV with each diastole, but the LV chamber is less dense than the aorta.
- Moderately severe AR (3+): The LV chamber is equal in density with the ascending aorta.
- Severe AR (4+): Complete, dense opacification of the LV chamber occurs on the first beat and the LV is more densely opacified than the ascending aorta.
- Intra-aortic balloon counterpulsation is contraindicated in patients with severe AR.
Histologic Findings
Histological valvular findings in patients with AR depend on the cause of the patient's AR. Patient with congenital abnormalities can usually be easily characterized noninvasively or grossly at the time of surgery or during pathological inspection. Aortic root dilatation may be present in up to 25% of patients with AR due to bicuspid valve. Many patients with a bicuspid aortic valve have concurrent aortopathy including connective tissue and cellular abnormalities that predispose to aortic dilation, aneurysm, and dissection.[8]
Maurer G. Aortic regurgitation. Heart. Jul 2006;92(7):994-1000. [Medline].
Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. Mar 15 1999;83(6):897-902. [Medline].
Feldman T. Rheumatic heart disease. Curr Opin Cardiol. Mar 1996;11(2):126-30. [Medline].
Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation. Apr 13 1999;99(14):1851-7. [Medline].
Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. Sep 23 2008;52(13):e1-142. [Medline]. [Full Text].
Keane MG, Pyeritz RE. Medical management of Marfan syndrome. Circulation. May 27 2008;117(21):2802-13. [Medline]. [Full Text].
Ortiz JT, Shin DD, Rajamannan NM. Approach to the patient with bicuspid aortic valve and ascending aorta aneurysm. Curr Treat Options Cardiovasc Med. Dec 2006;8(6):461-7. [Medline].
Friedman T, Mani A, Elefteriades JA. Bicuspid aortic valve: clinical approach and scientific review of a common clinical entity. Expert Rev Cardiovasc Ther. Feb 2008;6(2):235-48. [Medline].
Palazzi C, D' Angelo S, Lubrano E, Olivieri I. Aortic involvement in ankylosing spondylitis. Clin Exp Rheumatol. May-Jun 2008;26(3 Suppl 49):S131-4. [Medline].
Schirmer M, Weidinger F, Sandhofer A, Gschwendtner A, Wiedermann C. Valvular disease and myocardial infarctions in a patient with Behçet disease. J Clin Rheumatol. Oct 2003;9(5):316-20. [Medline].
Eberhardt RT, Dhadly M. Giant cell arteritis: diagnosis, management, and cardiovascular implications. Cardiol Rev. Mar-Apr 2007;15(2):55-61. [Medline].
Chand EM, Freant LJ, Rubin JW. Aortic valve rheumatoid nodules producing clinical aortic regurgitation and a review of the literature. Cardiovasc Pathol. Nov-Dec 1999;8(6):333-8. [Medline].
Jain D, Halushka MK. Cardiac pathology of systemic lupus erythematosus. J Clin Pathol. Jul 2009;62(7):584-92. [Medline].
Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos HM. Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med. Jul 2007;120(7):636-42. [Medline].
Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Revisiting Libman-Sacks endocarditis: a historical review and update. Clin Rev Allergy Immunol. Jun 2009;36(2-3):126-30. [Medline].
Adachi O, Saiki Y, Akasaka J, Oda K, Iguchi A, Tabayashi K. Surgical management of aortic regurgitation associated with takayasu arteritis and other forms of aortitis. Ann Thorac Surg. Dec 2007;84(6):1950-3. [Medline].
Jeserich M, Ihling C, Holubarsch C. Aortic valve endocarditis with Whipple disease. Ann Intern Med. Jun 1 1997;126(11):920. [Medline].
Gaztanaga J, Pizarro G, Sanz J. Evaluation of cardiac valves using multidetector CT. Cardiol Clin. Nov 2009;27(4):633-44. [Medline].
Morello A, Gelfand EV. Cardiovascular magnetic resonance imaging for valvular heart disease. Curr Heart Fail Rep. Sep 2009;6(3):160-6. [Medline].
Myerson SG. Valvular and hemodynamic assessment with CMR. Heart Fail Clin. Jul 2009;5(3):389-400, vi-vii. [Medline].
Picano E, Pibarot P, Lancellotti P, Monin JL, Bonow RO. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol. Dec 8 2009;54(24):2251-60. [Medline].
Bekeredjian R, Grayburn PA. Valvular heart disease: aortic regurgitation. Circulation. Jul 5 2005;112(1):125-34. [Medline].
Bhudia SK, McCarthy PM, Kumpati GS, Helou J, Hoercher KJ, Rajeswaran J, et al. Improved outcomes after aortic valve surgery for chronic aortic regurgitation with severe left ventricular dysfunction. J Am Coll Cardiol. Apr 3 2007;49(13):1465-71. [Medline].
Rahimtoola SH. Choice of Prosthetic Heart Valve in Adults An Update. J Am Coll Cardiol. Jun 1 2010;55(22):2413-2426. [Medline].
Sampat U, Varadarajan P, Turk R, Kamath A, Khandhar S, Pai RG. Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients. J Am Coll Cardiol. Jul 28 2009;54(5):452-7. [Medline].
Bostwick DG, Bensch KG, Burke JS, Billingham ME, Miller DC, Smith JC, et al. Whipple's disease presenting as aortic insufficiency. N Engl J Med. Oct 22 1981;305(17):995-8. [Medline].
Goldbarg SH, Halperin JL. Aortic regurgitation: disease progression and management. Nat Clin Pract Cardiovasc Med. May 2008;5(5):269-79. [Medline].

